scholarly journals Melatonin Prevents Brain Damage and Neurocognitive Impairment Induced by Plasmodium Berghei ANKA Infection in Murine Model of Cerebral Malaria

2020 ◽  
Vol 10 ◽  
Author(s):  
Brenda Jaqueline de Azevedo Ataide ◽  
Nayara Kauffmann ◽  
Nívia de Souza Franco Mendes ◽  
Marjorie Lujan Marques Torres ◽  
Larissa Medeiros dos Anjos ◽  
...  
Keyword(s):  
Cerebral Malaria ◽  
Brain Damage ◽  
Murine Model ◽  
Plasmodium Berghei ◽  
Neurocognitive Impairment ◽  
Plasmodium Berghei Anka

scholarly journals Plasmodium berghei ANKA infection causes brain damage in mice resistant to cerebral malaria

2008 ◽  
Vol 2 (Suppl 1) ◽  
pp. P55
Author(s):  
Marie-France Penet ◽  
Frank Kober ◽  
Sylviane Confort-Gouny ◽  
Yann Le Fur ◽  
Christiane Dalmasso ◽  
...  
Keyword(s):  
Cerebral Malaria ◽  
Brain Damage ◽  
Plasmodium Berghei ◽  
Plasmodium Berghei Anka

Ginger Extract Has An Ability To Safe C57BL / 6-WT Mice From Cerebral Malaria Produced By Plasmodium Berghei ANKA

2018 ◽  
pp. 1
Author(s):  
سالم رمضان على السريتى ◽  
نوارة امراجع الازيرق العمارى
Keyword(s):  
Cerebral Malaria ◽  
Plasmodium Berghei ◽  
Plasmodium Berghei Anka ◽  
Ginger Extract

scholarly journals Efficacy of Proveblue (Methylene Blue) in an Experimental Cerebral Malaria Murine Model

2013 ◽  
Vol 57 (7) ◽  
pp. 3412-3414 ◽  
Author(s):  
Jérome Dormoi ◽  
Sébastien Briolant ◽  
Camille Desgrouas ◽  
Bruno Pradines
Keyword(s):  
Methylene Blue ◽  
Cerebral Malaria ◽  
Murine Model ◽  
Plasmodium Berghei ◽  
Active Metabolite ◽  
Line Treatment ◽  
First Line ◽  
Experimental Cerebral Malaria ◽  
Content Type ◽  
First Line Treatment

ABSTRACTAlthough 100% of untreated mice infected withPlasmodium bergheidied with specific signs of cerebral malaria and 100% of mice treated with 3 mg/kg dihydroartemisinin, the active metabolite of artesunate, which is used as the first-line treatment for severe malaria, also died but showed no specific signs of cerebral malaria, 78% of mice treated with 10 mg/kg Proveblue (methylene blue) and 78% of mice treated with a combination of 3 mg dihydroartemisinin and 10 mg/kg Proveblue survived and showed no specific signs of cerebral malaria or detectable parasites.

Cloned Lines of Plasmodium berghei ANKA Differ in Their Abilities To Induce Experimental Cerebral Malaria

1998 ◽  
Vol 66 (9) ◽  
pp. 4093-4099 ◽  
Author(s):  
Véronique Amani ◽  
Mariama Idrissa Boubou ◽  
Sylviane Pied ◽  
Myriam Marussig ◽  
David Walliker ◽  
...  
Keyword(s):  
Cerebral Malaria ◽  
Plasmodium Berghei ◽  
Plasmodium Berghei Anka ◽  
Experimental Cerebral Malaria

MDR1A (ABCB1)-Deficient CF-1 Mutant Mice are Susceptible to Cerebral Malaria Induced by Plasmodium Berghei ANKA

2008 ◽  
Vol 94 (5) ◽  
pp. 1139-1142 ◽  
Author(s):  
Sylvie Barraud de Lagerie ◽  
Christine Fernandez ◽  
Michèle German-Fattal ◽  
Jean-Charles Gantier ◽  
François Gimenez ◽  
...  
Keyword(s):  
Cerebral Malaria ◽  
Plasmodium Berghei ◽  
Mutant Mice ◽  
Plasmodium Berghei Anka

scholarly journals L‐arginine Supplementation and Thromboxane Synthase Inhibition Reverse Cerebral Ischemia in Murine Cerebral Malaria by Plasmodium berghei ANKA

2018 ◽  
Vol 32 (S1) ◽  
Author(s):  
Aline Silva Moreira ◽  
Vanessa Estato Freitas Almeida ◽  
Cesare Bianco‐Júnior ◽  
Claudio Tadeu Daniel‐Ribeiro ◽  
Eduardo Vera Tibiriçá ◽  
...  
Keyword(s):  
Cerebral Ischemia ◽  
Cerebral Malaria ◽  
Plasmodium Berghei ◽  
Plasmodium Berghei Anka ◽  
Thromboxane Synthase ◽  
Arginine Supplementation
Sign in / Sign up

Export Citation Format

Share Document